Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenström Macroglobulinemia

NCT02844361 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Waldenström Macroglobulinemia

Interventions

PROCEDURE: autologous stem cell transplantation
DRUG: conventional chemotherapy

Sponsor

Institute of Hematology & Blood Diseases Hospital, China